Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orthomyxoviridae Infections | 6 | 2022 | 248 | 2.520 |
Why?
|
| Influenza A virus | 6 | 2022 | 456 | 1.550 |
Why?
|
| Reactive Oxygen Species | 7 | 2022 | 2077 | 1.430 |
Why?
|
| Pneumonia | 2 | 2022 | 2133 | 0.380 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 3798 | 0.380 |
Why?
|
| Mitochondria | 2 | 2020 | 3520 | 0.350 |
Why?
|
| Toll-Like Receptor 7 | 3 | 2020 | 172 | 0.330 |
Why?
|
| Endosomes | 2 | 2019 | 520 | 0.260 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2024 | 212 | 0.260 |
Why?
|
| Pneumococcal Infections | 2 | 2020 | 497 | 0.250 |
Why?
|
| Inflammation | 4 | 2022 | 10638 | 0.250 |
Why?
|
| Influenza, Human | 3 | 2020 | 1479 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 5 | 2022 | 21827 | 0.170 |
Why?
|
| Membrane Glycoproteins | 3 | 2020 | 3768 | 0.170 |
Why?
|
| Organophosphorus Compounds | 1 | 2019 | 215 | 0.160 |
Why?
|
| Administration, Intranasal | 1 | 2019 | 446 | 0.150 |
Why?
|
| Mice | 9 | 2024 | 81183 | 0.140 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 713 | 0.130 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 459 | 0.120 |
Why?
|
| Respiratory Tract Diseases | 1 | 2020 | 722 | 0.120 |
Why?
|
| Animals | 11 | 2024 | 168757 | 0.120 |
Why?
|
| Virulence | 1 | 2017 | 1333 | 0.110 |
Why?
|
| Interleukin-17 | 1 | 2019 | 899 | 0.110 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 658 | 0.110 |
Why?
|
| Immunity, Innate | 2 | 2020 | 2958 | 0.100 |
Why?
|
| Piperidines | 1 | 2019 | 1602 | 0.100 |
Why?
|
| Neoplasms | 1 | 2020 | 21683 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 1061 | 0.100 |
Why?
|
| Virus Replication | 1 | 2019 | 2534 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 1790 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2020 | 2133 | 0.080 |
Why?
|
| Neutrophils | 1 | 2019 | 3719 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3047 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 10180 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2017 | 2987 | 0.060 |
Why?
|
| Lung | 2 | 2022 | 9856 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2020 | 3445 | 0.060 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2022 | 90 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2024 | 11124 | 0.050 |
Why?
|
| Disease Progression | 1 | 2017 | 13284 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2022 | 424 | 0.040 |
Why?
|
| Male | 5 | 2024 | 350118 | 0.040 |
Why?
|
| Endothelium | 1 | 2022 | 778 | 0.040 |
Why?
|
| Pandemics | 1 | 2019 | 8388 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2019 | 597 | 0.040 |
Why?
|
| Morbidity | 1 | 2022 | 1769 | 0.040 |
Why?
|
| Prostate | 1 | 2024 | 1774 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2020 | 1125 | 0.030 |
Why?
|
| Aorta | 1 | 2022 | 2061 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2017 | 23403 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2024 | 2942 | 0.030 |
Why?
|
| Fetus | 1 | 2020 | 1880 | 0.030 |
Why?
|
| Placenta | 1 | 2020 | 1698 | 0.020 |
Why?
|
| Monocytes | 1 | 2020 | 2596 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2022 | 3279 | 0.020 |
Why?
|
| Humans | 5 | 2024 | 744343 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2022 | 4456 | 0.020 |
Why?
|
| Pregnancy | 2 | 2022 | 29144 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2022 | 9734 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3086 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14557 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18029 | 0.010 |
Why?
|
| Female | 2 | 2022 | 380194 | 0.010 |
Why?
|
Concepts
(63)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_